Cellectar Biosciences Stock (NASDAQ: CLRB) stock price, news, charts, stock research, profile.
Open | $3.830 |
Close | $3.980 |
Volume / Avg. | 1.769M / 1.817M |
Day Range | 3.790 - 4.070 |
52 Wk Range | 1.300 - 4.450 |
Market Cap | $49.522M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 15.38% |
Days to Cover | 1.71 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cellectar Biosciences (NASDAQ: CLRB) through any online brokerage.
Other companies in Cellectar Biosciences’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and Bolt Biotherapeutics (NASDAQ:BOLT).
The latest price target for Cellectar Biosciences (NASDAQ: CLRB) was reported by Roth MKM on Thursday, March 28, 2024. The analyst firm set a price target for 28.00 expecting CLRB to rise to within 12 months (a possible 594.79% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $4.03 last updated March 28, 2024 at 7:40 PM EDT.
There are no upcoming dividends for Cellectar Biosciences.
Cellectar Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Cellectar Biosciences.
Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.